ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

24 hedge funds and large institutions have $59.6M invested in Alpine Immune Sciences, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
9
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$927K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$248K
3
DS
DRW Securities
Illinois
$184K
4
AWCI
Alpine Woods Capital Investors
New York
$114K
5
BlackRock
BlackRock
New York
$192K

Top Sellers

1
BI
BVF Inc
California
$4.87M
2
Millennium Management
Millennium Management
New York
$0
3
SIM
Spark Investment Management
New York
$0
4
Wells Fargo
Wells Fargo
California
$0
5
Vanguard Group
Vanguard Group
Pennsylvania
$1.64M
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
– -$88K -10,993 Closed
PWM
27
Perigon Wealth Management
California
– -$1K -150 Closed
Barclays
28
Barclays
United Kingdom
– -$1K -134 Closed
1
2